- €6.65bn
- €7.52bn
- $2.09bn
Brief: Qiagen Says Thierry Bernard To Step Down As Chief Executive Officer
Brief: Qiagen NV Raises FY Adjusted EPS Target To About $2.38 CER
Brief: Qiagen To Acquire Parse Biosciences
Brief: Qiagen To Return About $500 Million To Shareholders Through Synthetic Share Repurchase
Brief: Qiagen Secures European Ce-Ivdr Certification For Full Qiastat-Dx Portfolio
Brief: Qiagen Gains U.S. Clearance Of Higher-Throughput Qiastat-Dx Rise
Brief: Qiagen N.V. Announces $750 Million Convertible Bonds Due 2032
Brief: Qiagen Announces Placement Of New Net Share Settled Convertible Bonds
Brief: Qiagen Launches Non-US Offering Of Net Share Settled Convertible Bonds
Brief: Qiagen Reports Q2 2025 Net Sales $534 Million, Adjusted EPS $0.6
Europe Research Roundup: Compass Group, Cranswick, Informa
Live Markets: AI's "low hanging fruit" is in Europe
Brief: Qiagen NV Elects Stephen Rusckowski As Chairman Of Supervisory Board
Brief: QIAGEN, GENCURIX announce QIAcuity Digital PCR IVD Assay Development Partnership
Brief: Qiagen & Incyte Announce Precision Medicine Collaboration To Develop Companion Diagnostics For Patients With Mutant Calr-Expressing Myeloproliferative Neoplasms
Brief: Foresight Diagnostics And Qiagen Announce Strategic Partnership To Advance Development Of Companion Diagnostic Kits For Lymphoma
Brief: Qiagen Acquires Genoox For $70 Million Plus $10 Million In Milestones
Brief: Qiagen - H. Rusckowski To Succeed Lawrence A. Rosen As Chairman Of Supervisory Board Following AGM
Brief: Qiagen To Propose Initiation Of Annual Cash Dividend At AGM